Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
39.9M
-
Shares change
-
-9.67M
-
Total reported value, excl. options
-
$165M
-
Value change
-
-$103M
-
Put/Call ratio
-
1.94
-
Number of buys
-
59
-
Number of sells
-
-56
-
Price
-
$4.12
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q1 2022
143 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q1 2022.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.9M shares
of 161M outstanding shares and own 24.87% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (6.87M shares), Frazier Life Sciences Management, L.P. (5.24M shares), BlackRock Inc. (3.89M shares), Versant Venture Management, LLC (3.56M shares), Deep Track Capital, LP (2.99M shares), VANGUARD GROUP INC (2.73M shares), Palo Alto Investors LP (2.33M shares), STATE STREET CORP (970K shares), GEODE CAPITAL MANAGEMENT, LLC (864K shares), and Nuveen Asset Management, LLC (761K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.